Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by davewhoon May 14, 2021 3:57pm
179 Views
Post# 33205266

RE:RE:Interesting, anyone know this guy?

RE:RE:Interesting, anyone know this guy?Senior Editor

Team – InvestorIntel


Chris Thompson

Sr Editor

Chris Thompson, CFA, MBA, P.Eng is the President & Director of Research at eResearch Corp. and a Sr. Editor and Director for InvestorIntel Corp. Chris Thompson has over 15 years of experience in software, financial technology, telecommunications, and information technology. He started his capital markets career in mining equity research at Scotia Capital in 2009 before joining Wellington West Capital Markets in 2010. Subsequently, Chris spent three years at an NYC-based, investment bank focusing on mergers & acquisitions. Most recently, he was at Global Maxfin Capital, M Partners, and Ubika Research in equity research roles, focusing on the mining, technology, business information, and health technology sectors. In 2019, Chris acquired eResearch Corp., a company founded in 2000, that is a respected source for institutional-quality, equity research focused primarily on small- and mid-cap companies. Chris holds an Engineering degree from the University of Toronto, an MBA in Investment Management from Concordia University, and is a CFA® charterholder.


<< Previous
Bullboard Posts
Next >>